News & Events
- Today is the last day for trading in the subscription rights for subscribing for shares in Genetic Analysis
- Today the subscription period in Genetic Analysis subsequent offering begins
- Genetic Analysis first day of trading excluding subscription rights
- Genetic Analysis publishes Simplified disclosure document relating to the previously announced subsequent offering
- Genetic Analysis Last day of trading including subscription rights
- Correction: Publication of Q1 report January – March 2025
- Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting
- Genetic Analysis announces details of Subsequent Offering following directed issue
- Publication of Q1 report January – March 2025
- Minutes from the Annual General Meeting 2024 in Genetic Analysis AS
- Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates
- Correction: Genetic Analysis announces placement of a directed share issue of NOK 12.8 million
- Genetic Analysis announces proposed changes to the Board
- Notice of annual general meeting
- Genetic Analysis announces proposed changes to the Board